CD8A and hepatocellular carcinoma: In another study of 32 HCC patients who underwent radiofrequency ablation or chemoablation with an injection of tremelimumab, the increase in CD8+ T cells identified by a 6-week tumor biopsy was associated with improved survival time [163].